Apyx Medical Corporation (APYX)
NASDAQ
3.11
+0.03 (+0.97%)
Real-time Data
01:30 PM
Day's Range
3.093.24
52 wk Range
1.705.08
Financial Statements - APYX - Apyx Medical Corporation
Revenue
52.84M▲ 9.9%
Net Income
-11.10M▲ 52.9%Net Margin -21.0%
EBITDA
-4.59M▲ 72.7%
Free Cash Flow
-9.11M▲ 51.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 52.84M | 48.10M | 52.34M | 44.51M | 48.51M | 27.71M |
| Cost of Goods | 19.80M | 18.74M | 18.59M | 15.37M | 14.91M | 10.20M |
| Gross Profit | 33.04M | 29.36M | 33.75M | 29.13M | 33.60M | 17.50M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -6.44M | -18.84M | -19.95M | -23.56M | -14.44M | -20.08M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 92K | -161K | 226K | 509K | -373K | 479K |
| Pre Tax Income | -10.83M | -23.30M | -21.28M | -22.91M | -14.82M | -19.40M |
| Income Tax | 270K | 252K | -2.43M | 367K | 380K | -7.50M |
| Net Income | -11.10M | -23.55M | -18.85M | -23.27M | -15.20M | -11.90M |
| EPS Basic | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 | -0.35 |
| EPS Diluted | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 | -0.35 |
| Basic Shares Outstanding | 41.09M | 35.54M | 34.62M | 34.51M | 34.33M | 34.21M |
| Diluted Shares Outstanding | 41.09M | 35.54M | 34.62M | 34.51M | 34.33M | 34.21M |
| Ebit | -5.24M | -17.40M | -18.80M | -22.89M | -14.81M | -19.36M |
| Ebitda | -4.59M | -16.80M | -17.71M | -22M | -13.90M | -18.47M |
| Net Income Continuous Operations | -11.10M | -23.55M | -18.85M | -23.27M | -15.20M | -11.90M |
| Minority Interests | -106K | 96K | 137K | 94K | 28K | 10K |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
